EUVIMEDEUVIMED entdecken
Leitlinie

ISCN 2024: Summary of Revisions and New Nomenclature

Nicole L Chia, Sarah Moore, Ros J Hastings

Cytogenetic and Genome Research · 28.03.2025 · 165 (1) · 1-8

DOI: 10.1159/000544969 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Cytogenetic and Genome Research, online erschienen am 28.03.2025. Verfasst von Nicole L Chia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Terminology as Topic, Genomics, Genome, Human. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The International Standing Committee on Human Cytogenomic Nomenclature (ISCN SC) considered feedback from the cytogenomics community to provide a more user friendly and organized presentation of general rules, improved example descriptions, more representative examples, and additional abbreviations. The ISCN 2024 edition represents one of the most significant reviews. Nomenclature for describing the findings of genomic mapping has been included for the first time. A key achievement of the Committee in preparing the ISCN 2024 is the provision of standardized nomenclature to ensure consistency in the ISCN description of findings irrespective of the cytogenomic technology used. This report highlights the main changes in the ISCN 2024 compared to previous editions and is a guide to assist in the transition to its implementation as the current nomenclature for describing cytogenomic findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Terminology as TopicGenomicsGenome, HumanHumans

Stichwörter der Autor:innen

CytogenomicGenome mappingISCNNomenclatureTargeted analysis

Autor:innen und Institutionen

  • Faculty of Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
  • Genetics and Molecular Pathology, SA Pathology, Adelaide, South Australia, Australia.
  • GenQA, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.

Zitieren

APA

Chia, N. L., Moore, S., & Hastings, R. J. (2025). ISCN 2024: Summary of Revisions and New Nomenclature. Cytogenetic and Genome Research, 165(1), 1-8. https://doi.org/10.1159/000544969

Vancouver

Chia NL, Moore S, Hastings RJ. ISCN 2024: Summary of Revisions and New Nomenclature. Cytogenetic and Genome Research. 2025;165(1):1-8. doi:10.1159/000544969

BibTeX
@article{Chia2025,
  author = {Chia, Nicole L and Moore, Sarah and Hastings, Ros J},
  title = {ISCN 2024: Summary of Revisions and New Nomenclature},
  journal = {Cytogenetic and Genome Research},
  year = {2025},
  volume = {165},
  number = {1},
  pages = {1--8},
  doi = {10.1159/000544969}
}
Kostenlos starten →